Guided Therapeutics (GTHP) Non-Current Assets (2010 - 2026)
Guided Therapeutics (GTHP) posted Non-Current Assets of $719000.0 for Q4 2025, up 591.35% sequentially from $104000.0 in Q3 2025, and up 297.24% YoY from $181000.0 in Q4 2024.
Guided Therapeutics (GTHP) Non-Current Assets (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Non-Current Assets for 16 years, with the latest figure at $719000.0 in Q4 2025.
- Quarterly Non-Current Assets rose 297.24% year-over-year to $719000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (up 297.24% YoY) and the FY2025 annual result came in at $719000.0, up 297.24% from the prior year.
- Non-Current Assets advanced to $719000.0 in Q4 2025 per GTHP's latest filing, from $104000.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $719000.0 in Q4 2025 and troughed at $104000.0 in Q3 2025.
- A 5-year average of $322450.0 and a median of $330500.0 in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2021 and 2025: Non-Current Assets surged 570.97% in 2021, then sank 49.51% in 2025.
- Over 5 years, Non-Current Assets stood at $403000.0 in 2021, then retreated by 10.17% to $362000.0 in 2022, then slipped by 23.76% to $276000.0 in 2023, then sank by 34.42% to $181000.0 in 2024, then surged by 297.24% to $719000.0 in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $719000.0, $104000.0, and $129000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 668,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 668,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Mar 31, 2023 | 342,000.00 |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 403,000.00 |
| Sep 30, 2021 | 416,000.00 |
| Jun 30, 2021 | 427,000.00 |